Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acquisition
Biotech
Concentra strikes again, circling up IGM Biosciences
Concentra Biosciences continues to scavenge for struggling biotechs, this time picking up antibody biotech IGM Biosciences for $1.25 per share.
Gabrielle Masson
Jul 1, 2025 9:58am
Lilly lands next-gen pain asset in $1B SiteOne acquisition
May 27, 2025 11:30am
Concentra swoops in to purchase struggling Kronos
May 1, 2025 3:07pm
Chimerix had 8 suitors: Why Jazz won out
Mar 21, 2025 5:17pm
Cell therapy biotech axes cancer trial, turns to autoimmune
Mar 19, 2025 5:35pm
Hookipa walks back Poolbeg purchase plan
Feb 20, 2025 1:34pm